Germline Variant-based Dose Optimization

Germline Variant-Based Dose Optimization is a pharmacogenomic strategy that systematically adjusts chemotherapeutic drug dosing based on inherited genetic variants to maximize efficacy and minimize toxicity in individual patients.

2

Publications

109

Citations

40

Authors

31

Institutions

Publications per year

2017–2026

1

Authors

40

  1. KL
    Karin Leunen

    KU Leuven, Belgium

    1 publications · 19 citations

    1

    h-index

  2. MK
    Miriam Koopman

    University Medical Center Utrecht, Netherlands

    1 publications · 90 citations

    1

    h-index

  3. SB
    Stan B. Kaye

    Royal Marsden NHS Foundation Trust, United Kingdom

    1 publications · 19 citations

    1

    h-index

  4. RL
    Rob L. H. Jansen

    Maastricht University, Netherlands

    1 publications · 90 citations

    1

    h-index

  5. CA
    Carin A.T.C. Lunenburg

    Leiden University Medical Center, Netherlands

    1 publications · 90 citations

    1

    h-index

1–5 of 40

Venues

  1. European Journal of Cancer

    1 publications · 90 citations

    1

    h-index

1–1